Answers are grounded in this paper and cite their sources.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces multiorgan dysfunction by rampaging throughout the body 1 , 2 . As dermatological lesions affect 1%–20% of patients with coronavirus disease 2019 (COVID-19) 3 , the skin may not be exempt. Skin biopsy samples reportedly have low SARS-CoV-2 loads 4 , 5 ; however, it remains unclear whether SARS-CoV-2 directly causes cutaneous manifestations, and if so, what is the cell tropism of the virus in the skin and whether skin contact poses a risk of viral transmission.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: